BIYKEM BOZKURT to Endothelin Receptor Antagonists
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Endothelin Receptor Antagonists.
Connection Strength
0.047
-
Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation. 2001 Feb 20; 103(7):973-80.
Score: 0.047